tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gene Mannheimer, 21 are a BUY (72.41%), 8 are a HOLD (27.59%).
Analyst Gene Mannheimer, currently employed at FREEDOM CAPITAL MARKETS, carries an average stock price target met ratio of 71.79% that have a potential upside of 21.02% achieved within 188 days. Previously, Gene Mannheimer worked at COLLIERS, TOPEKA.
Gene Mannheimer’s has documented 70 price targets and ratings displayed on 9 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on NUTX, Nutex Health at 25-Sep-2026.
Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for CPSI (COMPUTER PROGRAMS AND SYSTEMS) at 10/30/2015. The price target of $43 was fulfilled within 26 days with a profit of $9.71 (29.17%) receiving and performance score of 11.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Apr-2023
$55
$18.28 (49.78%)
$44
2 years 7 months 13 days ago
(22-Feb-2024)
1/2 (50%)
$13.3 (31.89%)
323
Buy Since 17-Oct-2023
$45
$8.28 (22.55%)
$45
2 years 9 months 3 days ago
(02-Jan-2024)
2/2 (100%)
$6.22 (16.04%)
97
Buy Since 19-Dec-2022
$60
$23.28 (63.40%)
$40
3 years 7 months 8 days ago
(27-Feb-2023)
1/2 (50%)
$24.75 (70.21%)
115
Hold Since 08-Aug-2022
$57
$20.28 (55.23%)
$92
4 years 1 months 27 days ago
(08-Aug-2022)
1/2 (50%)
$4.05 (7.65%)
29
Which stock is Gene Mannheimer most bullish on?
Which stock is Gene Mannheimer most reserved on?
What Year was the first public recommendation made by Gene Mannheimer?
